Science and Technology – phagogen

Science and Technology

Therapeutic development strategy

LDL Deposition in Intima

LDL Removal by Macrophages

Macrophage Apoptosis

Defects in Efferocytosis

Plaque Formation

Atherosclerosis

Chemicals, Abs, Natural Products

Efferocytosis Reprogramming

Enhanced Efferocytosis

Resolution of Plaque

Atherosclerosis

Market Share and Expansion Strategy

Statin class drugs
기존 스타틴 기반 치료의 한계

Limitations of existing statin-based treatments

기존 스타틴 기반 치료의 한계

Side effects: diabetes, myalgia, myositis

부작용: 당뇨병, 근육통, 근육염

Indirect treatment of atherosclerosis: slow therapeutic effect

동맥경화증의 간접치료 : 치료효과가 느림

Drugs based on promoting efferocytosis
사멸세포제거 촉진을 기반으로 한 약물

Therapeutics based on promoting efferocytosis

사멸세포 제거 촉진 기반 치료제

Targeting the cause of plaque formation -> Reducing plaque and inhibiting its formation (direct treatment for atherosclerosis) Rapid drug effect whe

플랑크 생성 원인을 타겟(사멸세포축적)->플라크 감소 및 형성 억제(죽상동맥경화증 직접 치료제)

Rapid drug effect when atherosclerosis occurs

죽상동맥경화증 발병 시 신속한 약물 효과

Excellent treatment effect compared to statin drugs

스타틴 계열 약물 대비 우수 치료 효과

Synergistic effect through combination administration with statin

병용 투여로 인한 치료 효과 증진

Copyright © Phagogen. All Rights Reserved.